共 31 条
- [1] Postuma RB, Poewe W, Litvan I, Et al., Validation of the MDS clinical diagnostic criteria for Parkinson's disease, Mov Disord, 33, 10, pp. 1601-1608, (2018)
- [2] Dorsey ER, Bloem BR., The Parkinson Pandemic-A Call to Action, JAMA Neurol, 75, 1, pp. 9-10, (2018)
- [3] Dorsey ER, Constantinescu R, Thompson JP, Et al., Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030, Neurology, 68, 5, pp. 384-386, (2007)
- [4] Yasuhara T., Neurobiology Research in Parkinson's Disease, Int J Mol Sci, 21, 3, (2020)
- [5] Athauda D, Foltynie T., The ongoing pursuit of neuroprotective therapies in Parkinson disease, Nat Rev Neurol, 11, 1, pp. 25-40, (2015)
- [6] Fayyad M, Salim S, Majbour N, Et al., Parkinson's disease biomarkers based on alpha-synuclein, J Neurochem, 150, 5, pp. 626-636, (2019)
- [7] Acharya S, Lumley AI, Devaux Y., Targeting regulatory RNAs at the heart of Parkinson's disease, Eur Heart J, 44, 23, pp. 2059-2060, (2023)
- [8] Rosenthal LS, Yang J, Mao X., Dysregulated miRNAs mark Parkinson's disease progression, Nat Aging, 1, 3, pp. 241-242, (2021)
- [9] Lewis A, Mehta S, Hanna LN, Et al., Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohn's Disease Phenotype, Inflamm Bowel Dis, 21, 8, pp. 1926-1934, (2015)
- [10] Amjad N, Yang R, Li L, Et al., Decrease of miR-19b-3p in Brain Microvascular Endothelial Cells Attenuates Meningitic Escherichia coli-Induced Neuroinflammation via TNFAIP3-Mediated NF-kappaB Inhibition, Pathogens, 8, 4, (2019)